According to our new research study on “US Mail Order Pharmacy Market Size and Forecast to 2030 – Country Analysis – by Drug Type, Product, and Mode of Order,” the market is expected to grow from US$ 43,728.62 million in 2022 to US$ 171,883.03 million by 2030; it is estimated to record a CAGR of 18.66% during 2022–2030. Factors such as the increasing incidences of chronic diseases and surging adoption of mail order pharmacy services for various healthcare needs fuel the US mail order pharmacy market growth.

Market Drivers

Increasing Incidences of Chronic Diseases

Chronic diseases such as diabetes, cardiovascular disorders, autoimmune disorders, and various cancer types are the leading causes of mortality worldwide. According to the National Association of Chronic Disease Directors 2022 report, nearly 40% of American adults have multiple chronic conditions (MCC). Additionally, the National Health Council report reveals that chronic conditions account for more than 75% of the total healthcare costs in the US. Heart disease, cancer, mental disorders, and pulmonary conditions rank among the 5 most expensive health conditions, based on total annual healthcare spending in the US. Similarly, diabetes is one of the life-threatening chronic diseases with no functional cure. Mail-order pharmacy services are typically offered for buying drugs prescribed for chronic conditions such as high cholesterol, asthma, high blood pressure, diabetes, and depression. Through this, the customer gets medicine for 90 days rather than getting prescriptions refilled every month. Therefore, in addition to the increasing incidences of chronic diseases—medication nonadherence, population aging, and convenience over traditional methods drive growth of the US mail-order pharmacy market.

Increasing Adoption of Mail-Order Pharmacy Services for Specific Healthcare

Mail-order pharmacy services have shown a significant growth pattern in the last few years, and these businesses are currently involved in mailing drugs based on billions of prescriptions annually worldwide. Multiple retail giants have ventured into the mail-order pharmacy business owing to the growing popularity and increasing adoption of this model. In July 2020, CapitalRx, a fast-growing pharmacy benefit manager (PBM), collaborated with Walmart to enable cost savings in the purchase of prescription drugs. To avoid waiting in queues at drugstores, consumers have shifted to digital pharmacy services. As mail-order pharmacy service providers have witnessed a rise in the volume of orders since March 2020, various companies have expanded their service pipelines to meet the magnifying demand. CAPSULE CORPORATION (New York) has launched its services in three other major cities—Minneapolis, Boston, and Chicago—since April 2020 due to an upsurge in the demand for mail-order pharmacy services with the rise in COVID-19 cases. In New York, the company delivered medicines within 2 hours of order placement. The platform also allows patients to transfer their refills from their old pharmacies to CAPSULE CORPORATION’s platform. The growing demand for mail-order pharmacies has also paved the way for many new companies in this space to offer a wide range of services

Based on Product the US mail-order pharmacy market, by product, is segmented into dermal care products, anti-diabetic medicines, cardiovascular medicines, blood pressure medicines, asthma management products, cold & flu medicines, painkillers, antacids, and others. The dermal care product segment held a larger market share in 2022 and cardiovascular medicines segment is anticipated to register a higher CAGR of 22.89% during 2020-2030. Skincare products are available with better access, lower transaction and product costs, greater convenience, and optimum anonymity. According to an article published by McKinsey & Company in May 2023, the e-commerce business in the beauty segment nearly quadrupled from 2015 to 2022, with its share exceeding 20%.

The major players in the US mail order pharmacy market are CVS Health Corp, Walmart Inc, Envirotainer AB, Able Freight Services LLC, Deutsche Post AG, GeniusRx, Geisinger Health, Geisinger Health, Humana, Inc., Ridgeway Pharmacy LLC and The Cigna Group. These leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base for tapping prevailing business opportunities.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com